Is Jounce Therapeutics, Inc. (JNCE) a Buy, Sell, or Hold?
NASDAQ : JNCE
Jounce Therapeutics, Inc. — Competitors
$1.88 USD
$0 (0.0%)
- Volume
- 11.6M
- Average Volume
- 3.47M
- Market Capitalization
- $98.95M
- P/E Ratio
- -1.90
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.37
- Year Low
- $0.58
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.37
JNCE vs. The Competition
| Properties | JNCE | AADI | BLI | CYT |
|---|---|---|---|---|
| Market Cap | $98.95M | $94.89M | $86.61M | $108.71M |
| Shares Outstanding | $52.64M | $46.29M | $72.17M | $36M |
| P/E Ratio | -1.9 | -1.49 | -0.85 | -2.42 |
| EPS | -0.99 | -1.67 | -1.42 | -1.25 |
| Day Low | 1.88 | 2.015 | 1.145 | 3 |
| Day High | 1.93 | 2.19 | 1.3 | 3.09 |
| Year Low | 0.5773 | 1.21 | 0.9797 | 1.65 |
| Year High | 5.37 | 3.812 | 7.4 | 3.19 |
| Average Price 50 | 1.63977 | 2.5597 | 1.6458 | 3.0933 |
| Average Price 200 | 1.927253 | 2.15738 | 2.958775 | 2.8556 |
| Volume | 11.6M | 62607 | 2.29M | 1.01M |
| Average Volume | - | - | - | - |